Each and every biologics and mesalamine/sulfasalazine were no longer linked to extreme COVID-19 outcomes in inflammatory bowel illness (IBD) sufferers, in step with findings from…
Each and every biologics and mesalamine/sulfasalazine were no longer linked to extreme COVID-19 outcomes in inflammatory bowel illness (IBD) sufferers, in step with findings from…